Labcorp EBITDA 2010-2024 | LH

Labcorp annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Labcorp EBITDA for the quarter ending March 31, 2024 was $0.476B, a 0.83% increase year-over-year.
  • Labcorp EBITDA for the twelve months ending March 31, 2024 was $1.307B, a 18.07% decline year-over-year.
  • Labcorp 2023 annual EBITDA was $1.303B, a 33.99% decline from 2022.
  • Labcorp 2022 annual EBITDA was $1.974B, a 45.56% decline from 2021.
  • Labcorp 2021 annual EBITDA was $3.626B, a 2.64% increase from 2020.
Labcorp Annual EBITDA
(Millions of US $)
2023 $1,303
2022 $1,974
2021 $3,626
2020 $3,532
2019 $1,907
2018 $1,878
2017 $1,838
2016 $1,771
2015 $1,457
2014 $1,152
2013 $1,223
2012 $1,256
2011 $1,184
2010 $1,188
2009 $1,139
Labcorp Quarterly EBITDA
(Millions of US $)
2024-03-31 $476
2023-12-31 $24
2023-09-30 $393
2023-06-30 $414
2023-03-31 $472
2022-12-31 $76
2022-09-30 $507
2022-06-30 $540
2022-03-31 $851
2021-12-31 $540
2021-09-30 $953
2021-06-30 $891
2021-03-31 $1,242
2020-12-31 $1,478
2020-09-30 $1,660
2020-06-30 $442
2020-03-31 $-48
2019-12-31 $492
2019-09-30 $484
2019-06-30 $477
2019-03-31 $454
2018-12-31 $445
2018-09-30 $477
2018-06-30 $508
2018-03-31 $448
2017-12-31 $475
2017-09-30 $460
2017-06-30 $457
2017-03-31 $446
2016-12-31 $412
2016-09-30 $446
2016-06-30 $490
2016-03-31 $422
2015-12-31 $352
2015-09-30 $429
2015-06-30 $440
2015-03-31 $236
2014-12-31 $277
2014-09-30 $300
2014-06-30 $310
2014-03-31 $265
2013-12-31 $275
2013-09-30 $303
2013-06-30 $327
2013-03-31 $318
2012-12-31 $275
2012-09-30 $303
2012-06-30 $333
2012-03-31 $345
2011-12-31 $306
2011-09-30 $298
2011-06-30 $285
2011-03-31 $295
2010-12-31 $293
2010-09-30 $287
2010-06-30 $322
2010-03-31 $286
2009-12-31 $267
2009-09-30 $286
2009-06-30 $296
2009-03-31 $291
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.190B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.631B 21.23
Becton Dickinson (BDX) United States $67.642B 19.14
West Pharmaceutical Services (WST) United States $23.823B 42.69
Cardinal Health (CAH) United States $23.375B 13.37
Align Technology (ALGN) United States $18.864B 36.42
Cooper (COO) United States $18.112B 26.71
Henry Schein (HSIC) United States $9.120B 16.22
DENTSPLY SIRONA (XRAY) United States $5.718B 14.81
Merit Medical Systems (MMSI) United States $5.034B 27.59
Patterson (PDCO) United States $2.315B 11.42
CONMED (CNMD) United States $2.267B 20.56
STAAR Surgical (STAA) United States $2.173B 83.45
Atrion (ATRI) United States $0.803B 42.90
Lifevantage (LFVN) United States $0.081B 10.51
Pro-Dex (PDEX) United States $0.068B 34.31